21 May 2013
Keywords: genesis, invests, china, liang, fang, equity, partners
Article | 27 March 2006
Genesis Equity Partners, a subsidiary of the Genesis Technology Group, has acquired an equity interest in Liang Fang Pharmaceuticals, a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 March 2006
© 2013 thepharmaletter.com